Genetic Testing Market Is Estimated To Witness High Growth Owing To Increasing Demand for Personalized Medicine
Genetic Testing Market |
The global genetic testing market is estimated to be valued at US$ 16.22 Bn in 2023 and is expected to exhibit a CAGR of 12.4% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Genetic testing involves the analysis of an individual's DNA to identify
genetic variations or mutations that may be associated with specific diseases
or conditions. This market offers a wide range of tests including diagnostic
tests, carrier tests, predictive tests, and presymptomatic tests. These tests
provide crucial information for healthcare professionals and individuals,
enabling personalized treatment and prevention strategies. The increasing
demand for personalized medicine, advancements in technology, and the growing
incidence of genetic diseases are driving the growth of the genetic testing
market.
Market key trends:
One key trend in the genetic testing market is the increasing adoption of
direct-to-consumer (DTC) genetic testing. DTC genetic testing allows
individuals to access and analyze their own genetic information without
involving healthcare professionals. This trend is driven by the availability of
affordable testing kits and the convenience of accessing genetic information
from the comfort of one's own home. However, this trend also raises concerns
regarding the accuracy and interpretation of test results, as well as privacy
and ethical issues.
In conclusion, the global genetic testing market is poised for high growth due
to the increasing demand for personalized medicine. The key trend of DTC
genetic testing is expected to further drive market growth, although challenges
related to accuracy, interpretation, and privacy need to be addressed.
PEST Analysis:
Political: The political factors that may impact the genetic testing market
include government regulations and policies regarding genetic testing, privacy
and data protection laws, and healthcare policies. Governments may impose
restrictions or regulations on genetic testing to ensure ethical and
responsible use of genetic information.
Economic: The economic factors influencing the genetic testing market include
healthcare expenditure, reimbursement policies, and the affordability of
genetic testing services. Rising healthcare expenditure and favorable
reimbursement policies can drive the growth of the market, making genetic
testing more accessible to the general population.
Social: Social factors such as increasing awareness and acceptance of genetic
testing, growing interest in personalized medicine, and the rise in genetic
diseases can drive the demand for genetic testing. As people become more aware
of the benefits of genetic testing, the market is likely to expand.
Technological: Technological advancements in genetic testing techniques and
equipment, such as next-generation sequencing and non-invasive prenatal
testing, are driving the growth of the genetic testing market. These
technologies offer greater accuracy, efficiency, and cost-effectiveness, making
genetic testing more accessible and attractive.
Key Takeaways:
The global
genetic testing market is expected to witness high growth, exhibiting a
CAGR of 12.4% over the forecast period (2023-2030). This growth can be
attributed to increasing awareness and acceptance of genetic testing,
advancements in technology, and rising healthcare expenditure.
In terms of market size, the genetic testing market is projected to reach US$
16.22 billion by 2023. This significant market size indicates the growing
demand for genetic testing services worldwide.
Regionally, North America is expected to be the fastest-growing and dominating
region in the genetic testing market. This can be attributed to the presence of
a well-developed healthcare infrastructure, favorable reimbursement policies,
and increasing prevalence of genetic disorders in the region.
Key players operating in the genetic testing market include 23&Me Inc.,
Qiagen NV, Eurofins Scientific, PerkinElmer Inc., Illumina Inc., Danaher
Corporation, Myriad Genetics Inc., Abbott Laboratories, F. Hoffmann-La Roche
Ltd., Quest Diagnostics Incorporated, BioRad Laboratories Inc., and DiaSorin
S.p.A. These key players contribute to the growth of the market through product
innovation, strategic partnerships, and expansions in different regions.
Read More:
https://www.marketwebjournal.com/genetic-testing-market-is-estimated-to-witness-high-growth/
Comments
Post a Comment